Welcome to our dedicated page for Momentus SEC filings (Ticker: MNTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Momentus Inc. filings document the regulatory record of a Nasdaq-listed commercial space company with Class A common stock under MNTS and warrants under MNTSW. Its 8-K disclosures cover shareholder letters, Regulation FD communications, preliminary operating updates, Vigoride mission press releases, material agreements, private placements, pre-funded warrants, convertible notes, warrant amendments, and debt-conversion matters.
Momentus proxy statements document stockholder voting matters tied to board elections, auditor ratification, equity incentive plan amendments, advisory executive-compensation votes, and Nasdaq share-issuance approvals. The filing record also describes capital-structure changes, securities purchase agreements, warrant and convertible-debt mechanics, governance proposals, and formal event reporting connected to the company’s satellite technology, in-space transportation, and orbital-service business.
Rood John C. reported acquisition or exercise transactions in this Form 4 filing.
Momentus Inc. reported that Chief Executive Officer John C. Rood received a grant of 22,744 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A common stock and vests in three equal annual installments, subject to his continued employment.
Momentus Inc. reports that its Board approved a temporary reduction in the conversion price of its Junior Secured Convertible Promissory Note held by Yield Point NY LLC. As of February 20, 2026, the note had an outstanding principal balance of approximately $1.6 million.
The conversion price is being reduced from $19.9206 per share of Class A common stock to $5.28 per share, applicable to up to 81,555 shares. This lower price applies during the period from February 20, 2026 until March 25, 2026, or until all 81,555 shares are issued upon conversion, whichever occurs first, unless the company extends the offer.
Momentus Inc. reported the results of its 2026 Special Meeting of Stockholders held on February 6, 2026. Stockholders approved several proposals allowing the company to issue Class A common stock under existing Convertible Notes and Warrants, an Equity Line of Credit and related pre-funded warrants, and various Inducement Warrants, including warrants issued in October 2025, December 2025 and January 2026.
The Convertible Notes and Warrants Proposal passed with 8,382,509 votes for and 317,830 against, and similar margins supported the other issuance-related proposals. An Adjournment Proposal was also approved. However, a proposal to increase authorized Class A common stock from 250,000,000 to 260,000,000 shares, the Share Increase Proposal, did not receive approval despite 14,445,976 votes in favor and 941,345 against.
The company updates its at-the-market offering to cover up to $50,000,000 of common stock sold through A.G.P./Alliance Global Partners under an existing sales agreement. This total includes $21,621,572.40 of common stock previously sold under the program.
The company states it is no longer subject to Form S-3 General Instruction I.B.6 because the market value of common stock held by non-affiliates was at least $75.0 million as of February 9, 2026. The common stock trades on Nasdaq under the symbol MNTS, with a last reported price of $6.44 per share on February 9, 2026.
The company is updating its at-the-market offering program to permit sales of up to $4,177,347 of common stock under its existing sales agreement with A.G.P./Alliance Global Partners. This amount reflects the remaining capacity it can sell under Form S-3 General Instruction I.B.6 limits.
The public float used for these limits was $64,868,408, based on 3,842,710 non-affiliate shares at $16.88 per share. The company has already sold $17,445,455 of common stock under these rules in the past twelve months and may file future supplements if its public float increases.
Momentus Inc. is registering up to 1,903,871 shares of common stock for resale by existing holders. The shares come mainly from warrants issued in an early‑January 2026 private placement and from stock issued to settle vendor debt.
The company will not sell shares or receive proceeds from these resale transactions, though it has recently raised capital through multiple financings, warrant inducements and an at‑the‑market program. Momentus reports large accumulated deficits, continuing losses, very limited cash, and states there is substantial doubt about its ability to continue as a going concern without significant additional capital.
The filing also details prior Nasdaq listing compliance issues, reverse stock splits to maintain the minimum bid price, and numerous convertible notes and warrant structures that can be converted into common stock subject to ownership caps and stockholder‑approval thresholds, highlighting ongoing reliance on equity-linked financing.
Momentus Inc. is updating its special stockholder meeting to add a new financing-related proposal and revise several others. The virtual meeting will now be held on February 6, 2026. Stockholders are being asked to approve multiple issuances of Class A common stock tied to convertible notes, an equity line of credit, pre-funded and inducement warrants, and a 10 million share increase in authorized Class A common stock from 250,000,000 to 260,000,000 shares.
The company recently completed a 1-for-17.85 reverse stock split and entered into several warrant inducement and private placement deals that brought in cash but require Nasdaq Rule 5635(d) stockholder approval before related warrants can be exercised. These include up to 418,466 shares under October 2025 inducement warrants, 408,577 shares under December 2025 inducement warrants, and 925,926 shares under January 2026 warrants, each at an amended or stated exercise price of $5.40 per share where applicable.
The company notes that exercising these warrants for cash could provide approximately $16.4 million in additional gross proceeds across the inducement and January 2026 warrants, supporting its business plan, but would dilute existing holders and could pressure the stock price as more shares become eligible for resale. If stockholders do not approve key proposals, Momentus may need to call repeated meetings and seek alternative financing, which it states could affect its ability to continue as a going concern and increase transaction costs.
Momentus Inc. reported that it has exchanged an existing unsecured convertible promissory note held by A.G.P./Alliance Global Partners for a new note on substantially the same terms, keeping the aggregate principal amount at $500,000. The original note, issued on June 30, 2025, was convertible into shares of Class A common stock at a price of $29.8095 per share after a 1‑for‑17.85 reverse stock split on December 17, 2025.
Under the new exchange note dated January 9, 2026, the conversion price has been reset to $10.00 per share of common stock, which means more shares could be issued if the note is converted. The exchange was conducted under the Securities Act exemption in Section 3(a)(9), and the company has filed the new unsecured convertible promissory note as an exhibit.
Momentus Inc. is updating its 2026 Special Meeting agenda and seeking stockholder approval for several capital-related actions tied to outstanding warrants and financing arrangements. A new Proposal 7 asks approval, under Nasdaq rules, to issue up to 925,926 shares of Class A common stock upon exercise of January 2026 Warrants from a recent $5 million private placement. Proposals 3 and 5 seek approval to issue up to 418,466 and 408,577 shares, respectively, upon exercise of October and December 2025 inducement warrants, whose exercise prices were reduced to $5.40 per share after a 1-for-17.85 reverse stock split.
The meeting will also consider increasing authorized Class A shares from 250,000,000 to 260,000,000, approving share issuances tied to a convertible notes and warrants deal and an equity line of credit, and authorizing adjournments if votes are insufficient. The company explains that warrant exercises have already provided significant capital and that its ability to continue as a going concern depends on maximizing capital-raising opportunities, while warning that full warrant exercise would dilute existing holders and could pressure the stock price.